NL-OMON24515招募中不适用
TOP-1: Omission of radiotherapy in elderly patients with low risk breast cancer
eiden University Medical Center (LUMC)0 个研究点目标入组 1,200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Low-risk invasive breast cancer: tumour < 1 cm, grade 1-2 or tumour 1-2 cm, grade 1
- •2. Registration within 3 months after Breast Conserving Surgery
- •3. R0 resection
- •4. HER2 negative
- •5. pN0 or pN0(itc) disease
- •6. ER positive > 50%
- •7. Age ≥70 years
- •8. Indication for standard radiotherapy
- •9. Willing to complete quality of life questionnaires and geriatric assessments
- •10. Female
排除标准
- •1. Indication for hormonal therapy
- •2. Bilateral
研究者
相似试验
已完成
不适用
One-week hypofractionated radiotherapy in elderly and frail patients with newly diagnosed glioblastomaGlioblastomaJPRN-UMIN000032672Yokohama city university40
招募中
不适用
eoadjuvant short-term radiotherapy followed by surgery versus surgery alone for patients over 70 years of age with local advanced rectal cancer and who are medically unfit for standard neoadjuvant radiochemotherapy treatmentOptimal therapy for patients > 70 years with rectal cancerMalignant neoplasm of rectumCancerISRCTN74475000South City Hospital Rostock (Klinikum Suedstadt Rostock) (Germany)800
进行中（未招募）
1 期
Thoracic Radiotherapy plus Durvalumab in Elderly and/or frail NSCLC stage III patients unfit for chemotherapy - Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacyunresectable stage III NSCLC (Non–small-cell lung cancer)MedDRA version: 20.0Level: LLTClassification code: 10025053Term: Lung cancer non-small cell stage IIIA Class: 10029104MedDRA version: 20.0Level: LLTClassification code: 10025054Term: Lung cancer non-small cell stage IIIB Class: 10029104MedDRA version: 21.1Level: PTClassification code: 10029519Term: Non-small cell lung cancer stage III Class: 100000004864MedDRA version: 21.1Level: PTClassification code: 10029521Term: Non-small cell lung cancer stage IIIB Class: 100000004864MedDRA version: 20.0Level: LLTClassification code: 10025052Term: Lung cancer non-small cell stage III Class: 10029104MedDRA version: 21.1Level: PTClassification code: 10029520Term: Non-small cell lung cancer stage IIIA Class: 100000004864CTIS2024-513948-28-00Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH57
招募中
2 期
Thoracic Radiotherapy plus Durvalumab in Elderly and/or frail NSCLC stage III patients unfit for chemotherapy - Employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy2024-513948-28-00Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH57
尚未招募
不适用
Increasing dose of radiation in rectal cancer patientcan lead to better sustained tumour response and avoid surgeryCTRI/2020/03/024184Tata Memorial Hospital